Balixafortide is a Selective and Well-Tolerated Peptidic CXCR4 Antagonist
Despite the introduction of new targeted therapies and cytotoxic agents, chemotherapy-pretreated metastatic breast cancer (MBC) remains an essentially incurable disease with only moderate median overall survival (OS). over 20 human…